Crescent Biopharma (CBIO) Other Non-Current Liabilities (2013 - 2021)
Crescent Biopharma (CBIO) reported Other Non-Current Liabilities of $538,587 for Q3 2021, up 199.0% from $180,117 a year earlier and up 31.9% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Other Non-Current Liabilities (2013 - 2021) Analysis & Trends
At the end of FY2020, Crescent Biopharma posted Other Non-Current Liabilities of $264,329.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 1.6% (FY2015 to FY2020).
- By year, Other Non-Current Liabilities came in at $611,623 in FY2018 (-13.5%), $707,003 in FY2017 (-6.2%) and $753,579 in FY2016 (+209.3%).
- The Q3 2021 figure ranks as the highest quarterly Other Non-Current Liabilities since Q4 2018.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2017 (growth of 229.7%); the low point was Q2 2021 (a decline of 20.7%).
- Per Business Quant data, the three quarters before Q3 2021 came in at $408,323 (Q2 2021), $373,911 (Q1 2021) and $264,329 (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Crescent Biopharma | 401.35 Mn | -305.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 538,587.00 |
| Jun 30, 2021 | 408,323.00 |
| Mar 31, 2021 | 373,911.00 |
| Dec 31, 2020 | 264,329.00 |
| Sep 30, 2020 | 180,117.00 |
| Jun 30, 2020 | 515,144.00 |
| Mar 31, 2020 | 393,273.00 |
| Dec 31, 2018 | 611,623.00 |
| Sep 30, 2018 | 1.37 Mn |
| Jun 30, 2018 | 1.41 Mn |
| Mar 31, 2018 | 1.45 Mn |
| Dec 31, 2017 | 707,003.00 |
| Sep 30, 2017 | 1.53 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Mar 31, 2017 | 1.58 Mn |
| Dec 31, 2016 | 753,579.00 |
| Sep 30, 2016 | 1.76 Mn |
| Jun 30, 2016 | 1.68 Mn |
| Mar 31, 2016 | 250,143.00 |
| Dec 31, 2015 | 243,647.00 |
API Access
Crescent Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();